Status:
UNKNOWN
Effect of FGM on Glucose Control in Diabetic Patients
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to assess the effect of FGM on glycemic control compared with SMBG using a randomised controlled study design in adults with type 2 diabetes.
Detailed Description
Flash glucose monitoring (FGM) is a newly introduced Glucose Monitoring system. The aim of the study is to assess the effect of FGM on glycemic control compared with standard blood glucose monitoring (...
Eligibility Criteria
Inclusion
- \>18 years old;
- diagnosed as having diabetes who were willing to perform the study and complete the data collection;
- in stable condition prior to the study.
Exclusion
- pregnancy or attempting to conceive;
- known allergy to medical grade adhesive or isopropyl alcohol used to prepare the skin;
- skin lesions, scarring, redness, infection, or edema at the sensor application sites;
- patients whose conditions were extremely severe and not stable.
Key Trial Info
Start Date :
December 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT03785301
Start Date
December 20 2018
End Date
December 31 2019
Last Update
June 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing First Hostital
Nanjing, Jiangsu, China, 210000